Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Ann Oncol. 2022 Jun;33(6):658. doi: 10.1016/j.annonc.2022.03.003. Epub 2022 Mar 14.

¹ Department of Medicine, The University of Chicago Medical Center, Chicago, USA. Electronic address: gfleming@medicine.bsd.uchicago.edu.
² Interdisciplinary Cancer Service Hospital Riviera-Chablais Rennaz, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), Vaud, Switzerland.
³ IBCSG Statistical Center, Dana-Farber Cancer Institute, Boston, USA.
⁴ University of Calgary and Canadian Cancer Trials Group, Calgary, Canada.
⁵ Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, Australia.

No abstract available

Publication types